Tag Archives: advanced nonfunctional gastrointestinal

Novartis: study shows Afinitor® reduced the risk of progression in patients with advanced nonfunctional gastrointestinal and lung NET

Posted on 29, September 2015 by

In pivotal study, everolimus reduced risk of disease progression by 52%; showed 11.0-month median progression-free survival vs 3.9 months for placebo[1] Advanced, progressive, nonfunctional neuroendocrine tumors of GI or lung origin are rare forms of cancer with poor prognoses and … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Switzerland

Tagged , , ,